Trial Profile
Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2017
Price :
$35
*
At a glance
- Drugs Buprenorphine (Primary) ; Buprenorphine/naloxone (Primary)
- Indications Opioid-related disorders
- Focus Therapeutic Use
- Sponsors Reckitt Benckiser
- 07 Apr 2008 New trial record.